ABSTRACT WICK, WARREN E. (The Lilly Research Laboratories, Indianapolis, Ind.), AND WILLIAM S. BONIECE. In vitro and in vivo laboratory evaluation of cephaloglycin and cephaloridine. Appl. Microbiol. 13:248-253. 1965.-Two new antibiotics, structurally related to cephalothin, have been given the generic names cephaloglycin and cephaloridine. Cephaloglycin is the dipolar ion of 7-(D-a-aminophenylacetamido)-cephalosporanic acid. Cephaloridine is 7-[a-(2-thiophene)acetamidoj-3-(1-pyridylmethyl)-3-cephem-4-carboxylic acid betaine. These new compounds were evaluated simultaneously. The broad spectrum of activity observed in vitro and in vivo with both antibiotics, the good oral absorption obtained with cephaloglycin, and the stability of cephaloridine are emphasized. The data suggest that both antibiotics merit clinical trial in humans.
Two new antibiotics, structurally related to cephalothin (Chauvette et al., 1962; Boniece et al., 1962) , have been given the generic names cephaloglycin and cephaloridine. Cephaloglycin is the dipolar ion of 7-(D-a-amino-phenylacetamido) cephalosporanic acid. This antibiotic is a white crystalline solid soluble at about 8 mg/ml in distilled water at 25 C. Cephaloridine is 7- [a-(2-thiophene) acetamido]-3-(l-pyridylmethy]-3-cephem-4-carboxylic acid betaine, also a white crystalline solid, but soluble at >100 mg/ml in water at room temperature. Structures of these new compounds and of cephalothin are compared in Fig. 1 . The in vitro and in vivo biological activities of these new antibiotics were studied simultaneously. The broad spectrum of activity observed with both antibiotics, the good oral absorption obtained with cephaloglycin, and the stability of cephaloridine are emphasized. The data suggest that both antibiotics merit clinical trial in humans.
MATERIALS AND METHODS
Cultures. The bacteria used, both gram-positive and gram-negative, were different strains as determined by antigenic analysis, phage typing, or drug-sensitivity spectra.
Disc-plate sensitivity tests. Sensitivity tests were performed with Trypticase Soy Agar (BBL), except for Haemophilus strains for which Levinthal broth with 1.5% agar was used. Paper discs (6 mm) containing 30,g of ampicillin, cephalothin, cephaloglycin, cephaloridine, chloramphenicol, or tetracycline were employed. Agar plates were seeded by swabbing from undiluted overnight broth cultures. The discs were placed on the seeded agar, and the plates were examined for zones of inhibition after overnight incubation at 37 C.
Tube-dilution sensitivity tests. Trypticase Soy Broth (BBL) was the medium employed for all but the clostridia. For these, thioglycollate broth was utilized. For streptococci, pneumococci, and Neisseria, 5% defibrinated rabbit blood was added to the broth. The tubes were seeded from dilutions of standardized suspensions that gave inocula of 103 or 105 organisms per milliliter. In tests on staphylococci and gram-negative bacilli, minimal inhibitory concentration (MIC) end points were read after 12 and 24 hr of incubation at 37 C. Stability studies. For determining the extent of degradation of the antibiotics in broth solutions, with and without sensitive bacteria, chromatography methods and viable-cell count studies similar to those reported by Wick (1964) were employed.
Bactericidal activity. Bactericidal activity was detected by subculturing serial dilution tubes with a loop to fresh antibiotic-free broth, and by determining changes in viable-cell counts during the incubation of tube-dilution tests.
Penicillinase studies. Both Bacillus cereus and staphylococcal penicillinases were utilized. Phosphate buffer (pH 7.0) and enough of these enzymes to inactivate 100 units per ml of penicillin G in 1 hr at room temperature were employed. The concentration of the antibiotics exposed to the enzymes was 25 jg/ml. Degradation rates over the 24-hr period of observation were determined by biological assays. Mouse blood level studies. To determine blood levels, a disc-plate assay with Sarcina lutea PCl-1001-FDA was utilized. After oral administration of antibiotic, the mice were bled at intervals from the orbital sinus. The blood was collected in heparinized hematocrit tubes. These were allowed to fill by capillary action. (6 mm) were saturated with blood and immediately placed on seeded assay plates. This procedure permitted bleeding of the same mouse several times and eliminated any possibility of error due to time delay in collecting and assaying serum.
Experimental infections. Experimental infections were performed with groups of eight white mice (McAllister strain, 11 to 13 g). Decimal dilutions from fresh standardized suspensions were prepared in 5% hog gastric mucin and injected intraperitoneally. For streptococcal and pneumococcal infections, mucin was not necessary. Twofold dilutions of the antibiotics were administered orally or subcutaneously to five groups of mice at 1 and 5 hr after infection. The mice were observed for 7 days, and the ED50 and IDro values were calculated by the method of Reed and Muench (1938) . The EDwo iS the twice-administered dose required to cure 50% of the infected mice.
RESULTS AND DISCUSSION
Cephaloglycin and cephaloridine both display a wide spectrum of activity in vitro (Tables 1, 2 , and 3), comparable to that of cephalothin. However, against sensitive gram-positive bacteria, cephaloridine is the most active of the three structurally related antibiotics. Indeed, the activity of cephaloridine against these organisms approaches that of the penicillins.
As with cephalothin (Boniece et al., 1962) , 30-jig discs of cephaloglycin and cephaloridine have been chosen for laboratory use in the clinical trials. In Table 4 are shown the results of the therapy of experimental infections in mice with organisms sensitive to 30-,ug discs. Also given are the tube-dilution sensitivities of these organisms. Because of the instability of cephaloglycin in broth solutions, tube-dilution sensitivity tests on staphylococci and gram-negative bacilli should be read after only 12 hr of incubation. This instability problem is illustrated in Fig. 2 shown a diagrammatic representation of the bioautographs from chromatography studies done during a tube test. Also shown are the viable counts obtained from the tubes.
The stability of cephaloridine is demonstrated in Fig. 3 , in which are shown the results of similar chromatography studies done during a tube test with this antibiotic. These data are in agreement with the observations on stability made by biological assays and by physicochemical methods. With cephaloridine, tube-dilution end points can be read after the usual overnight incubation.
The good oral absorption obtained with cephaloglycin is evident from the therapeutic response (Table 4 ) observed with this route of administration, and from the blood-level studies summarized in Fig. 4 . When similar doses of cephaloglycin or penicillin V were given, blood levels of cephaloglycin were obtained that compare favorably with those observed with this oral penicillin.
Although cephaloridine has some degree of effectiveness in vivo (Table 4 ) against certain organisms after oral administration, the mouse blood-level studies (Fig. 4) suggest that the present form of this antibiotic is less readily absorbed than cephaloglycin or penicillin V.
It is evident from the data presented in Tables  5 and 6 inactivation of cephaloridine was much slower than that observed with penicillin G. The incorporation of human or horse serum in test media had no significant effect on the outcome of sensitivity tests.
